Together, these findings demonstrate that HMGB2 knockdown significantly inhibits cancer cell proliferation across a range of female-specific cancers, highlighting its critical role in tumor growth and suggesting its potential as a therapeutic target. Here, HMGB2 is linked to neoplasm.